Theseus Pharmaceuticals Statistics
Total Valuation
BMV:HIMS has a market cap or net worth of MXN 217.58 billion. The enterprise value is 215.72 billion.
Market Cap | 217.58B |
Enterprise Value | 215.72B |
Important Dates
The last earnings date was Monday, August 4, 2025.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 217.64M |
Shares Outstanding | n/a |
Shares Change (YoY) | +11.15% |
Shares Change (QoQ) | +4.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 196.85M |
Valuation Ratios
The trailing PE ratio is 59.60 and the forward PE ratio is 38.42.
PE Ratio | 59.60 |
Forward PE | 38.42 |
PS Ratio | 5.73 |
PB Ratio | 20.50 |
P/TBV Ratio | 28.54 |
P/FCF Ratio | 87.16 |
P/OCF Ratio | 44.10 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.84, with an EV/FCF ratio of 86.42.
EV / Earnings | 59.09 |
EV / Sales | 5.78 |
EV / EBITDA | 69.84 |
EV / EBIT | 88.87 |
EV / FCF | 86.42 |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 1.86.
Current Ratio | 4.98 |
Quick Ratio | 4.23 |
Debt / Equity | 1.86 |
Debt / EBITDA | 6.27 |
Debt / FCF | 7.89 |
Interest Coverage | 114.89 |
Financial Efficiency
Return on equity (ROE) is 41.88% and return on invested capital (ROIC) is 8.27%.
Return on Equity (ROE) | 41.88% |
Return on Assets (ROA) | 6.94% |
Return on Invested Capital (ROIC) | 8.27% |
Return on Capital Employed (ROCE) | 8.16% |
Revenue Per Employee | 23.20M |
Profits Per Employee | 2.23M |
Employee Count | 1,637 |
Asset Turnover | 1.71 |
Inventory Turnover | 5.26 |
Taxes
Income Tax | -1.03B |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1,008.30 |
200-Day Moving Average | 785.16 |
Relative Strength Index (RSI) | 42.76 |
Average Volume (20 Days) | 4,055 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, BMV:HIMS had revenue of MXN 37.97 billion and earned 3.65 billion in profits. Earnings per share was 14.88.
Revenue | 37.97B |
Gross Profit | 28.93B |
Operating Income | 2.47B |
Pretax Income | 2.63B |
Net Income | 3.65B |
EBITDA | 3.02B |
EBIT | 2.47B |
Earnings Per Share (EPS) | 14.88 |
Balance Sheet
The company has 21.59 billion in cash and 19.70 billion in debt, giving a net cash position of 1.89 billion.
Cash & Cash Equivalents | 21.59B |
Total Debt | 19.70B |
Net Cash | 1.89B |
Net Cash Per Share | n/a |
Equity (Book Value) | 10.61B |
Book Value Per Share | 47.00 |
Working Capital | 20.43B |
Cash Flow
In the last 12 months, operating cash flow was 4.93 billion and capital expenditures -2.44 billion, giving a free cash flow of 2.50 billion.
Operating Cash Flow | 4.93B |
Capital Expenditures | -2.44B |
Free Cash Flow | 2.50B |
FCF Per Share | n/a |
Margins
Gross margin is 76.20%, with operating and profit margins of 6.50% and 9.62%.
Gross Margin | 76.20% |
Operating Margin | 6.50% |
Pretax Margin | 6.91% |
Profit Margin | 9.62% |
EBITDA Margin | 7.95% |
EBIT Margin | 6.50% |
FCF Margin | 6.57% |
Dividends & Yields
BMV:HIMS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.15% |
Shareholder Yield | n/a |
Earnings Yield | 1.68% |
FCF Yield | 1.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BMV:HIMS has an Altman Z-Score of 5 and a Piotroski F-Score of 5.
Altman Z-Score | 5 |
Piotroski F-Score | 5 |